cyproterone acetate has been researched along with Adverse Drug Event in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
El Aridi, L; Feigerlova, E; Gillet, P; Klein, M; Maurier, A; Yelehe, M | 1 |
Collier, R | 1 |
Beyens, MN; D'Amico, A; Gourbil, M; Grandvuillemin, A; Gras, V; Massy, N; Miremont-Salamé, G; Petitpain, N | 1 |
Kant, AC; van Hunsel, FP; van Puijenbroek, EP | 1 |
4 other study(ies) available for cyproterone acetate and Adverse Drug Event
Article | Year |
---|---|
Adverse effects of gender-affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database.
Topics: Cardiovascular Diseases; Cyproterone Acetate; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Pharmacovigilance; Retrospective Studies; Transgender Persons | 2022 |
Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
Topics: Canada; Cyproterone Acetate; Drug Combinations; Drug Labeling; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Off-Label Use; Safety-Based Drug Withdrawals | 2013 |
Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Cyproterone Acetate; Drug-Related Side Effects and Adverse Reactions; Female; Hospitals, Public; Humans; Middle Aged; Retrospective Studies; Risk Factors; Thromboembolism; Young Adult | 2014 |
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis | 2014 |